The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 29, 2015
Filed:
Nov. 18, 2013
Applicant:
Ardea Biosciences, Inc., San Diego, CA (US);
Inventor:
Mark Chapman, San Diego, CA (US);
Assignee:
ARDEA BIOSCIENCES, INC., San Diego, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/18 (2006.01); A61K 31/185 (2006.01); A61K 31/44 (2006.01); A61K 31/519 (2006.01); A61K 31/685 (2006.01); A61K 31/7068 (2006.01); A61K 31/7076 (2006.01); A61K 31/4188 (2006.01); A61K 31/436 (2006.01); A61K 31/517 (2006.01); A61K 31/7064 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61N 5/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/18 (2013.01); A61K 31/185 (2013.01); A61K 31/4188 (2013.01); A61K 31/436 (2013.01); A61K 31/517 (2013.01); A61K 31/5377 (2013.01); A61K 31/7064 (2013.01); A61K 31/7068 (2013.01); A61K 45/06 (2013.01); A61N 5/00 (2013.01);
Abstract
The present invention relates to the field of oncology and provides compositions and methods for treating specific cancers, including non small cell lung cancer, breast cancer, thyroid cancer, pancreatic cancer, colon cancer, melanoma, hepatoma and adenocarcinoma. Particularly, compositions and methods involving administration, either simultaneously or sequentially, of pharmaceutical combinations comprising (S)—N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1 -(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide with other compounds, to patients suffering from cancer are described.